{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T09:31:02Z","timestamp":1773480662350,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","drugandalcoholdependence.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.drugalcdep.2018.02.018","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T18:41:54Z","timestamp":1522348914000},"page":"22-28","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications"],"prefix":"10.1016","volume":"187","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7819-6697","authenticated-orcid":false,"given":"Ashley Elizabeth","family":"Muller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny","family":"Bj\u00f8rnestad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Clausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3109\/10826087109057786","article-title":"Heroin addicts on methadone replacement: a study of dropouts","volume":"6","author":"Adams","year":"1971","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0010","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1360-0443.2011.03577.x","article-title":"A prospective, randomized, multicenter acceptability and safety study of direct buprenorphine\/naloxone induction in heroin-dependent individuals","volume":"107","author":"Amass","year":"2012","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0015","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1370\/afm.328","article-title":"Do patients treated with dignity report higher satisfaction, adherence, and receipt of preventive care?","volume":"3","author":"Beach","year":"2005","journal-title":"Ann. Fam. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2015.04.002","article-title":"Patient perspectives associated with intended duration of buprenorphine maintenance therapy","volume":"56","author":"Bentzley","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0025","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/S0027-9684(15)30175-9","article-title":"Opioid addiction and abuse in primary care practice: a comparison of methadone and buprenorphine as treatment options","volume":"104","author":"Bonhomme","year":"2012","journal-title":"J. Nat. Med. Assoc."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0030","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/eurpub\/ckv175.040","article-title":"Telephone interviews to assess non-response bias in a postal user experience survey","volume":"25","author":"Danielsen","year":"2015","journal-title":"Eur. J. Public Health"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0035","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1360-0443.1997.tb02866.x","article-title":"Patterns of symptom complaints in methadone maintenance patients","volume":"92","author":"Dyer","year":"1997","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0040","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0045","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1176\/appi.ps.201300235","article-title":"Medication-assisted treatment with methadone: assessing the evidence","volume":"65","author":"Fullerton","year":"2014","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0050","first-page":"113","article-title":"Variations in treatment organisation, practices and outcomes within the Norwegian opioid maintenance treatment programme","volume":"21","author":"Gjersing","year":"2011","journal-title":"Nor. Epidemiol."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2648.2005.03561.x","article-title":"A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication","volume":"52","author":"Gray","year":"2005","journal-title":"J. Adv. Nurs."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0060","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jsat.2013.10.004","article-title":"Leaving buprenorphine treatment: patients\u2019 reasons for cessation of care","volume":"46","author":"Gryczynski","year":"2014","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0065","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2017.09.024","article-title":"Constipation and other common symptoms reported by women and men in methadone and buprenorphine maintenance treatment","volume":"181","author":"Haber","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0070","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/14659891.2014.894589","article-title":"A comparison of methadone and buprenorphine\u2013naloxone as opioid substitution therapy: the patient perspective in NHS Lanarkshire","volume":"20","author":"Hill","year":"2015","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0376-8716(82)90021-7","article-title":"Symptom complaints of patients maintained on methadone, LAAM (methadyl acetate), and naltrexone at different times in their addiction careers","volume":"10","author":"Judson","year":"1982","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/jama.1973.03220060039009","article-title":"Medical safety and side effects of methadone in tolerant individuals","volume":"223","author":"Kreek","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0085","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/00005650-199706000-00009","article-title":"An evaluation of the impact of nonresponse bias on patient satisfaction surveys","volume":"35","author":"Lasek","year":"1997","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3109\/10826087909054596","article-title":"Side effects in methadone patients: a survey of self-reported complaints","volume":"14","author":"Longwell","year":"1979","journal-title":"Int. J. Addict."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0095","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3109\/16066350009005590","article-title":"Assessing client satisfaction with treatment for substance use problems and the development of the treatment perceptions questionnaire (TPQ)","volume":"8","author":"Marsden","year":"2009","journal-title":"Addict. Res."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0100","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/1475-6773.11194","article-title":"A demonstration of the impact of response bias on the results of patient satisfaction surveys","volume":"37","author":"Mazor","year":"2002","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0105","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2190\/4HEY-VWXL-DVR3-HAKV","article-title":"Comparison of web and mail surveys in collecting illicit drug use data: a randomized experiment","volume":"34","author":"McCabe","year":"2004","journal-title":"J. Drug Educ."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0110","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/j.1360-0443.2004.00764.x","article-title":"Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence","volume":"99","author":"Mitchell","year":"2004","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0115","series-title":"Vedr\u00f8rende valg av buprenorfinpreparat i Legemiddelassistert rehabilitering [Regarding the choice of bupreorphine preparation in opioid maintenance treatment]","author":"Norwegian Board of Health","year":"2008"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0120","unstructured":"Norwegian Directorate of Health, 2010. Nasjonal retningslinje for legemiddelassistert rehabilitering ved opioidavhengighet [National guidelines for opioid maintenance treatment, p. 137]. Norwegian Directorate of Health, Oslo."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0125","unstructured":"Norwegian Ministry of Health Care and Services, 1999. Lov om pasient- og brukerrettigheter (pasient- og brukerrettighetsloven) [Patient rights law]. In: Services, N.M.o.H.a.C. (Ed.) Oslo, Lovdata."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.drugpo.2008.07.004","article-title":"Why don\u2019t out-of-treatment individuals enter methadone treatment programs","volume":"21","author":"Peterson","year":"2010","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0135","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1080\/02791072.2009.10400539","article-title":"Premature discharge from methadone treatment: patient perspectives","volume":"41","author":"Reisinger","year":"2009","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0140","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1111\/add.12315","article-title":"Buprenorphine implants for treatment of opioid dependence: randomized comparison to placebo and sublingual buprenorphine\/naloxone","volume":"108","author":"Rosenthal","year":"2013","journal-title":"Addiction"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0145","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/MLR.0000000000000457","article-title":"Do differential response rates to patient surveys between organizations lead to unfair performance comparisons?: Evidence from the English Cancer Patient Experience Survey","volume":"54","author":"Saunders","year":"2016","journal-title":"Med. Care"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0150","first-page":"82","article-title":"Methadon und levomethadon\u2014Dosierung und nebenwirkungen [methadone and levomethadone\u2014dosage and side effects]","volume":"41","author":"Schoofs","year":"2014","journal-title":"Psychiat. Prax."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0155","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5055\/jom.2013.0152","article-title":"Consumer attitudes about opioid addiction treatment: a focus group study in New York City","volume":"9","author":"Sohler","year":"2013","journal-title":"J. Opioid Manage."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/00001786-200307000-00002","article-title":"Survey response rates and overall patient satisfaction scores: what do they mean?","volume":"18","author":"Spooner","year":"2003","journal-title":"J. Nurs. Care Qual."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/14659891.2010.526480","article-title":"Comparing methadone and suboxone in applied treatment settings: the experiences of maintenance patients in Lanarkshire","volume":"16","author":"Tanner","year":"2011","journal-title":"J. Subst. Use"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0170","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1080\/02791072.2014.921743","article-title":"Patient perspectives on buprenorphine\/naloxone: a qualitative study of retention during the starting treatment with agonist replacement therapies (START) study","volume":"46","author":"Teruya","year":"2014","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0175","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2011.10.014","article-title":"Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning","volume":"123","author":"Trujols","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2147\/PPA.S52060","article-title":"A critical analysis of user satisfaction surveys in addiction services: opioid maintenance treatment as a representative case study","volume":"8","author":"Trujols","year":"2014","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0185","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s12913-016-1595-z","article-title":"Evidence of non-response bias in the Press-Ganey patient satisfaction survey","volume":"16","author":"Tyser","year":"2016","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2015.09.001","article-title":"Buprenorphine dose induction in non-opioid-tolerant pre-release prisoners","volume":"156","author":"Vocci","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0195","series-title":"Statusrapport 2012: LAR Som Det Vil Bli Fremover? [National OMT Report]","author":"Waal","year":"2013"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0200","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1001\/jama.2008.574","article-title":"Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trial","volume":"300","author":"Woody","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0205","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jsm.12352","article-title":"The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study","volume":"11","author":"Yee","year":"2014","journal-title":"J. Sex. Med."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.2174\/1874473711104010028","article-title":"Buprenorphine and buprenorphine\/naloxone diversion, misuse, and illicit use: an international review","volume":"4","author":"Yokell","year":"2011","journal-title":"Curr. Drug Abuse Rev."},{"key":"10.1016\/j.drugalcdep.2018.02.018_bib0215","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3390\/ijerph6020787","article-title":"Attitudes toward methadone among out-of-treatment minority injection drug users: implications for health disparities","volume":"6","author":"Zaller","year":"2009","journal-title":"Int. J. Environ. Res. Pub. Health"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618301650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618301650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T11:42:45Z","timestamp":1539603765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618301650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":43,"alternative-id":["S0376871618301650"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.02.018","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissatisfaction with opioid maintenance treatment partly explains reported side effects of medications","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}